BTBD14B Antibody - #DF2450
Product: | BTBD14B Antibody |
Catalog: | DF2450 |
Description: | Rabbit polyclonal antibody to BTBD14B |
Application: | WB IHC |
Reactivity: | Human, Mouse, Rat |
Prediction: | Pig, Bovine, Horse, Dog |
Mol.Wt.: | 57 kDa; 57kD(Calculated). |
Uniprot: | Q96RE7 |
RRID: | AB_2839656 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF2450, RRID:AB_2839656.
Fold/Unfold
BEND8; BTB Domain Containing 14B; BTB/POZ domain-containing protein 14B; btbd14b; FLJ37383; NAC-1; NAC1; Nacc1; NACC1_HUMAN; Nucleus accumbens-associated protein 1;
Immunogens
Overexpressed in several types of carcinomas including ovarian serous carcinomas. Expression levels positively correlate with tumor recurrence in ovarian serous carcinomas, and intense immunoreactivity in primary ovarian tumors predicts early recurrence. Up-regulated in ovarian carcinomas after chemotherapy, suggesting a role in development of chemotherapy resistance in ovarian cancer.
- Q96RE7 NACC1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAQTLQMEIPNFGNSILECLNEQRLQGLYCDVSVVVKGHAFKAHRAVLAASSSYFRDLFNNSRSAVVELPAAVQPQSFQQILSFCYTGRLSMNVGDQFLLMYTAGFLQIQEIMEKGTEFFLKVSSPSCDSQGLHAEEAPSSEPQSPVAQTSGWPACSTPLPLVSRVKTEQQESDSVQCMPVAKRLWDSGQKEAGGGGNGSRKMAKFSTPDLAANRPHQPPPPQQAPVVAAAQPAVAAGAGQPAGGVAAAGGVVSGPSTSERTSPGTSSAYTSDSPGSYHNEEDEEEDGGEEGMDEQYRQICNMYTMYSMMNVGQTAEKVEALPEQVAPESRNRIRVRQDLASLPAELINQIGNRCHPKLYDEGDPSEKLELVTGTNVYITRAQLMNCHVSAGTRHKVLLRRLLASFFDRNTLANSCGTGIRSSTNDPRRKPLDSRVLHAVKYYCQNFAPNFKESEMNAIAADMCTNARRVVRKSWMPKVKVLKAEDDAYTTFISETGKIEPDMMGVEHGFETASHEGEAGPSAEALQ
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q96RE7 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Y54 | Phosphorylation | Uniprot | |
S140 | Phosphorylation | Uniprot | |
S141 | Phosphorylation | Uniprot | |
S145 | Phosphorylation | Uniprot | |
T150 | Phosphorylation | Uniprot | |
S151 | Phosphorylation | Uniprot | |
T158 | Phosphorylation | Uniprot | |
K167 | Sumoylation | Uniprot | |
K167 | Ubiquitination | Uniprot | |
K183 | Ubiquitination | Uniprot | |
S188 | Phosphorylation | Uniprot | |
K191 | Ubiquitination | Uniprot | |
K202 | Acetylation | Uniprot | |
K205 | Acetylation | Uniprot | |
S263 | Phosphorylation | Uniprot | |
S274 | Phosphorylation | Uniprot | |
S277 | Phosphorylation | Uniprot | |
S330 | Phosphorylation | Uniprot | |
K368 | Ubiquitination | Uniprot | |
T411 | Phosphorylation | Uniprot | |
S422 | Phosphorylation | Uniprot | |
T424 | Phosphorylation | Uniprot | |
K452 | Ubiquitination | Uniprot | |
S474 | Phosphorylation | Uniprot | |
K483 | Sumoylation | Uniprot | |
K483 | Ubiquitination | Uniprot | |
Y489 | Phosphorylation | Uniprot | |
K498 | Ubiquitination | Uniprot |
Research Backgrounds
Functions as a transcriptional repressor. Seems to function as a transcriptional corepressor in neuronal cells through recruitment of HDAC3 and HDAC4. Contributes to tumor progression, and tumor cell proliferation and survival. This may be mediated at least in part through repressing transcriptional activity of GADD45GIP1. Required for recruiting the proteasome from the nucleus to the cytoplasm and dendritic spines.
Nucleus. Cytoplasm.
Note: Distribution in the cytoplasm is dependent on phosphorylation.
Overexpressed in several types of carcinomas including ovarian serous carcinomas. Expression levels positively correlate with tumor recurrence in ovarian serous carcinomas, and intense immunoreactivity in primary ovarian tumors predicts early recurrence. Up-regulated in ovarian carcinomas after chemotherapy, suggesting a role in development of chemotherapy resistance in ovarian cancer.
Homooligomer; mediated by the BTB domain. Interacts with HDAC3 and HDAC4. Interacts (via BTB domain) with CUL3, PSMD7 AND RCOR1.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.